Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Down-regulation of EBAF in the heart with ventricular septal defects and its regulation by histone acetyltransferase p300 and transcription factors smad2 and cited2.

Su D, Li Q, Guan L, Gao X, Zhang H, Dandan E, Zhang L, Ma X.

Biochim Biophys Acta. 2013 Dec;1832(12):2145-52. doi: 10.1016/j.bbadis.2013.07.013.

2.

CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.

Yoon H, Lim JH, Cho CH, Huang LE, Park JW.

Biochim Biophys Acta. 2011 Dec;1813(12):2008-16. doi: 10.1016/j.bbamcr.2011.08.018.

3.

Epiblastic Cited2 deficiency results in cardiac phenotypic heterogeneity and provides a mechanism for haploinsufficiency.

MacDonald ST, Bamforth SD, Chen CM, Farthing CR, Franklyn A, Broadbent C, Schneider JE, Saga Y, Lewandoski M, Bhattacharya S.

Cardiovasc Res. 2008 Aug 1;79(3):448-57. doi: 10.1093/cvr/cvn101.

4.
5.

P300 plays a role in p16(INK4a) expression and cell cycle arrest.

Wang X, Pan L, Feng Y, Wang Y, Han Q, Han L, Han S, Guo J, Huang B, Lu J.

Oncogene. 2008 Mar 20;27(13):1894-904.

PMID:
17906698
6.

Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway.

Bamforth SD, Bragança J, Farthing CR, Schneider JE, Broadbent C, Michell AC, Clarke K, Neubauer S, Norris D, Brown NA, Anderson RH, Bhattacharya S.

Nat Genet. 2004 Nov;36(11):1189-96.

PMID:
15475956
7.

Cited2 modulates TGF-beta-mediated upregulation of MMP9.

Chou YT, Wang H, Chen Y, Danielpour D, Yang YC.

Oncogene. 2006 Sep 7;25(40):5547-60.

PMID:
16619037
9.

Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.

Zhang H, Xu C, Yang R, Chen H, Kong X, Qian L, Sheng Y, Sun W.

Exp Cell Res. 2015 Feb 15;331(2):369-76. doi: 10.1016/j.yexcr.2014.12.016.

PMID:
25576386
10.

CITED2 mutation links congenital heart defects to dysregulation of the cardiac gene VEGF and PITX2C expression.

Li Q, Pan H, Guan L, Su D, Ma X.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):895-9. doi: 10.1016/j.bbrc.2012.06.099.

PMID:
22735262
11.

CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation.

Kasper LH, Lerach S, Wang J, Wu S, Jeevan T, Brindle PK.

EMBO J. 2010 Nov 3;29(21):3660-72. doi: 10.1038/emboj.2010.235.

12.

A cell-autonomous role of Cited2 in controlling myocardial and coronary vascular development.

MacDonald ST, Bamforth SD, Bragança J, Chen CM, Broadbent C, Schneider JE, Schwartz RJ, Bhattacharya S.

Eur Heart J. 2013 Aug;34(32):2557-65. doi: 10.1093/eurheartj/ehs056.

13.

BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity.

Jun JH, Yoon WJ, Seo SB, Woo KM, Kim GS, Ryoo HM, Baek JH.

J Biol Chem. 2010 Nov 19;285(47):36410-9. doi: 10.1074/jbc.M110.142307.

14.
15.
16.
17.

Cooperative activation of Npr1 gene transcription and expression by interaction of Ets-1 and p300.

Kumar P, Pandey KN.

Hypertension. 2009 Jul;54(1):172-8. doi: 10.1161/HYPERTENSIONAHA.109.133033.

19.
20.

Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.

Saeed S, Logie C, Francoijs KJ, Frigè G, Romanenghi M, Nielsen FG, Raats L, Shahhoseini M, Huynen M, Altucci L, Minucci S, Martens JH, Stunnenberg HG.

Blood. 2012 Oct 11;120(15):3058-68. doi: 10.1182/blood-2011-10-386086.

Items per page

Supplemental Content

Support Center